Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular alterations in bladder cancer

T F Orntoft, H Wolf

    Urological Research
    |October 6, 1998
    PubMed
    Summary
    This summary is machine-generated.

    Transitional cell carcinoma (TCC) development involves chromosomal instability and alterations in tumor suppressor genes like p53. These molecular changes correlate with disease progression and patient survival, necessitating further clinical investigation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Oral hairy leukoplakia in human immunodeficiency virus positive patients: clinical and etiopathogenic aspects].

    Acta otorrinolaringologica espanola·1992
    Same author

    Reactivities of HIV-1 gag-derived peptides with antibodies of HIV-1-infected and uninfected humans.

    AIDS research and human retroviruses·1992
    Same author

    Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells.

    European journal of immunology·1992
    Same author

    Localization and identification of T-(Gal beta 1-3GalNAc alpha 1-O-R) and T-like antigens in experimental rat bladder cancer.

    The Journal of urology·1992
    Same author

    Human urinary bladder carcinoma glycoconjugates expressing T-(Gal beta(1-3)GalNAc alpha 1-O-R) and T-like antigens: a comparative study using peanut agglutinin and poly- and monoclonal antibodies.

    Cancer research·1992
    Same author

    Determination of placental ferritin (PLF)-positive lymphocytes in women in early stages of breast cancer.

    International journal of cancer·1992
    Same journal

    Erratum to: Is routine ureteral stenting necessary after uncomplicated ureteroscopic lithotripsy for lower ureteral stones larger than 1 cm?

    Urological research·2017
    Same journal

    2002 30(th) Munich Endourological Symposium 10-11 October 2002.

    Urological research·2014
    Same journal

    Ellagica acid inhibits arylamine N-acetyltransferase activity and DNA adduct formation in human bladder tumor cell lines (T24 and TSGH 8301).

    Urological research·2014
    Same journal

    Biomolecular mechanism of urinary stone formation involving osteopontin.

    Urological research·2012
    Same journal

    Renal tubular epithelial cell injury, apoptosis and inflammation are involved in melamine-related kidney stone formation.

    Urological research·2012
    Same journal

    Role of 1 week of antibiotic prophylaxis before percutaneous nephrolithotomy.

    Urological research·2012
    See all related articles

    Area of Science:

    • Oncology
    • Genetics
    • Molecular Biology

    Background:

    • Transitional cell carcinoma (TCC) development is characterized by accumulating molecular alterations.
    • Studies reveal general chromosomal instability in TCC, with specific chromosome losses occurring at different stages.
    • Activation of oncogenes and frequent alterations of tumor suppressor genes, particularly p53, are implicated.

    Discussion:

    • Loss of heterozygosity for chromosome 9 occurs early, while other chromosomes are affected during tumor progression.
    • Tumor suppressor genes, including p53, p16, and p15, play crucial roles in cell cycle control and apoptosis.
    • Downregulation of glycosylation genes, such as ABO, and altered expression of adhesion molecules are observed in high-grade tumors.

    Key Insights:

    • p53 alterations (loss and mutation) are frequent and play a key role in TCC development.

    Related Experiment Videos

  • Molecular alterations correlate with clinical outcomes like survival, progression, invasion, and recurrence.
  • Functional proteomic analysis has identified potential biomarkers for TCC grade and stage.

    • Outlook:

    • Molecular models of TCC development can be constructed based on current findings.
    • Clinical validation of these molecular findings and biomarkers is urgently required.
    • Further research is needed to determine the predictive value of specific genetic alterations.